Yüklüyor......
Rivaroxaban Delivery and Reversal at a Venous Flow Rate
OBJECTIVE: Rivaroxaban is an oral anticoagulant that directly targets both free factor Xa and factor Xa in complex with its protein cofactor, factor Va, in the prothrombinase complex. It is approved in the United States for the prophylaxis of deep vein thrombosis and stroke in patients with atrial f...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3629550/ https://ncbi.nlm.nih.gov/pubmed/23023369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.112.300053 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|